Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
M. Amin Khan0
Date of Patent
February 5, 2019
Patent Application Number
15830378
Date Filed
December 4, 2017
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
